Standard Biotools | FLDM - Operating Profit


Standard Biotools reported $-23.47M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Illumina USD 256M 6M Dec/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Nikon Corporation JPY -98.8B 95.16B Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sony JPY 510.1B 2.18T Dec/2025
Standard Biotools USD -23.47M 230K Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Waters USD 270.52M 78.4M Dec/2025